Achillion Pharmaceuticals CEO Michael Kishbauch's 2007 pay jumps 44% to $1.2M
Achillion Pharmaceuticals reports 2007 executive compensation
By ExecPay News
Published: April 24, 2008
Achillion Pharmaceuticals reported fiscal year 2007 executive compensation information on April 24, 2008.
In 2007, five executives at Achillion Pharmaceuticals received on average a compensation package of $541K, a 24% increase compared to previous year.
Average pay of disclosed executives at Achillion Pharmaceuticals
Michael Kishbauch, Chief Executive Officer, received $1.2M in total, which increased by 44% compared to 2006. 59% of Kishbauch's compensation, or $719K, was in option awards. Kishbauch also received $127K in non-equity incentive plan, $363K in salary, as well as $11K in other compensation.
Milind Deshpande, Chief Scientific Officer, received a compensation package of $528K, which increased by 50% compared to previous year. 50% of the compensation package, or $265K, was in salary.
Gautam Shah, Senior Vice President and Chief Compliance Officer, earned $415K in 2007, a 23% increase compared to previous year.
Mary Kay Fenton, Chief Financial Officer, received $413K in 2007, which increases by 52% compared to 2006.
John Pottage, Chief Medical Officer, earned $131K in 2007, a 64% decrease compared to previous year.
Related executives
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
John Pottage
Achillion Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 24, 2008.